| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |